Prognostic impact of CD133 expression in Endometrial Cancer Patients

Prognostic impact of CD133 expression in Endometrial Cancer Patients

Abstract To assess the impact of CD133 expression on the prognosis of endometrioid endometrial carcinoma (EEC). We retrospectively assessed CD133 expression in tissue microarray of 116 surgically treated FIGO I-III EEC. Tumors with ≥10% of CD133-expressing cells were considered CD133-positive (CD133...

Full description

Bibliographic Details
Main Authors: G. Mancebo, J. M. Sole-Sedeno, O. Pino, E. Miralpeix, S. Mojal, L. Garrigos, B. Lloveras, P. Navarro, J. Gibert, M. Lorenzo, I. Aran, R. Carreras, F. Alameda
Format: Article
Language:English
Published: Nature Publishing Group 2017-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-08048-0

Internet

https://doi.org/10.1038/s41598-017-08048-0

Similar Items